Evaluation of a commercial targeted NGS panel for tumor mutation burden assessment in FFPE tissue

被引：1
|
作者：
Fang, Peng [1 ]
Yan, Zhenyu [1 ]
Quyen Vu [2 ]
Smith, David [2 ]
Galderisi, Chad [2 ]
Spittle, Cynthia S. [1 ]
Li, Jin [1 ]
机构：
[1] MolecularMD Corp, Cambridge, MA USA
[2] MolecularMD Corp, Portland, OR USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3614
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3614
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A 500-Gene Panel to Detect Tumor Mutation Burden of Tissue and Plasma Samples from Lung Cancer Patients
    Xiao, S.
    Mao, R.
    Lin, R.
    Wang, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S694 - S694
  • [42] Validation of a Novel Tumor Mutation Burden Assay Using a 130 Gene Tumor Only Targeted Sequencing Panel Covering Less Than 0.25 Megabases
    Joshi, R. P.
    Nabet, B. Y.
    Yang, S.
    Costa, H.
    Stehr, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1172 - 1173
  • [43] Clinical assay development and validation of multiplex immunofluorescent (mIHC) marker panel for evaluation of tumor infiltration myeloid cells in FFPE tissue sections
    Yi, Lan
    Juco, Jonathan
    Mahmood, Ashhad
    Laterza, Omar
    Garrido, Charo
    Yi, Lan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [44] The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
    Zhang, K.
    Tang, Y.
    Xu, X.
    Zhang, S.
    Tao, W.
    Rao, Z.
    Wu, F.
    An, S.
    Liu, J.
    Yang, J.
    Hou, T.
    Zhang, L.
    Zhang, Y.
    Liu, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1070 - S1070
  • [45] The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
    Zhang, K.
    Tang, Y.
    Xu, X.
    Tao, W.
    Rao, Z.
    Wu, F.
    An, S.
    Liu, J.
    Yang, J.
    Hou, T.
    Zhang, L.
    Zhang, Y.
    Liu, L.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S709 - S710
  • [46] Defining tissue requirements for a reliable detection of tumor mutational burden (TMB) in clinical FFPE samples.
    Schildhaus, Hans-Ulrich
    Herold, Thomas
    Worm, Karl
    Stoss, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Development of New Multianalyte NGS Controls with Microsatellite Instability, Tumor Mutation Burden and Loss of Heterozygosity Variants
    Liu, L.
    Gan, Q.
    Hu, R.
    Pursley, B.
    Waggoner, P.
    Wagner, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S114 - S114
  • [48] A targeted semi-conductor based next-generation sequencing (NGS) test to characterize microsatellite instability in FFPE tumor samples
    Kraltcheva, Anelia
    El-Difrawy, Sameh
    Kamat, Asha
    Au-Young, Janice
    Cawley, Simon
    Sadis, Seth
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis
    Li, Dan
    Wang, Dong
    Johann Jr, Donald J.
    Hong, Huixiao
    Xu, Joshua
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 248 (21) : 1918 - 1926
  • [50] A targeted NGS solution to evaluate gene expression signature of the tumor microenvironment from 40 NSCLC FFPE and matched fresh frozen samples
    Ku, Yuan-Chieh
    Tom, Warren
    Sun, Yongming
    Pankov, Alex
    Looney, Tim
    Hyland, Fiona
    Au-Young, Janice
    Mongan, Ann
    CANCER RESEARCH, 2017, 77
12345